ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AZN Astrazeneca Plc

12,096.00
-14.00 (-0.12%)
20 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -14.00 -0.12% 12,096.00 12,086.00 12,092.00 12,118.00 12,038.00 12,090.00 1,525,268 16:35:02
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.47 187.42B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 12,110p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 12,432.00p.

Astrazeneca currently has 1,550,189,338 shares in issue. The market capitalisation of Astrazeneca is £187.42 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 31.47.

Astrazeneca Share Discussion Threads

Showing 3726 to 3749 of 6150 messages
Chat Pages: Latest  150  149  148  147  146  145  144  143  142  141  140  139  Older
DateSubjectAuthorDiscuss
05/1/2021
01:45
Where a share was has no bearing on where it is now!
freddie ferret
04/1/2021
23:31
GSK down from £18 to £14 in 12 months.

AZN down from £76 to £74 in the same period.

I think we have a winner.

:-)

davius
04/1/2021
23:07
That's true Monty - there's always bulls and bears. But this share was nearly £100 not so long ago and if you really are shorting that's the thing to bear in mind. But I do agree you with you on the potential for GSK to do really well this year
mercury123
04/1/2021
23:02
Down from 8200p in 4 weeks, some traders thinking the same has me. That's what makes a market bulls and bears.
montyhedge
04/1/2021
22:50
Mercury123,

I agree very risky!

Monty has declared his short position, although I doubt he ever trades but I wish he'd take his drivel elsewhere.

Doubt he'd like it if some AZN BB holders started negative GSK BB comments. Seems he hasn't anything better to do.

beckers2008
04/1/2021
18:53
I wouldn't be short monty - too risky. Fine not being long but really risky being short
mercury123
04/1/2021
18:12
Can't see how you can be short on this share. ESP when there are so many better candidates at the mo
bogman1
04/1/2021
18:01
Who knows the story of the chicken and pig. One day the chicken says to the pig, eggs and bacon selling well for breakfast, let's merge, great said the pig. We will make a fortune says the chicken. Then the pig thought about it, but chicken you just lay eggs everyday, I get carved up for the bacon.Chicken says that's why a called it a merger and not a takeover.
montyhedge
04/1/2021
17:57
What I see 45% premium, ok got to pay up, they may have to pay more we will see. Paying part cash, that's ok can borrow the money, but seems they will have 15% of Astra, two seats on the board. Now that would be ok for a bid say a big pharma company.Surely not a smaller company, seems more of a merger. In the long run if all works out great, but short term I don't know.Problem for me long GSK, short Astra, they act in pairs, one goes up they both go up, go down they seem to both go down, lol.
montyhedge
04/1/2021
16:58
Thanks Beckers, not very often I agree with Motley, on pretty much anything. But this bit looks spot on:

AstraZeneca raised a lot of eyebrows recently with an offer to acquire Alexion Pharmaceuticals (NASDAQ:ALXN) for $39 billion in a combination of cash and AstraZeneca stock. This deal probably won't close until the second half of 2021, but AstraZeneca will gain the Soliris/Ultomiris franchise when it does.

Soliris is a complement inhibitor launched in 2007 to treat paroxysmal nocturnal hemoglobinuria (PNH), a rare disorder that causes some patients' immune systems to attack healthy blood cells. Over the years, Alexion funneled a lot of Soliris profits into expanding its addressable patient population and succeeded. At its current growth rate, Soliris franchise sales will reach $6 billion next year.

In 2018, Alexion successfully launched a longer-lasting version of its lead drug called Ultomiris, which requires a maintenance dose delivered through intravenous infusion every other month. While less expensive biosimilar versions of Soliris could become available several years from now, its maintenance dose needs to be infused every other week.

A drug that doesn't stick around at therapeutic concentrations very long isn't just an annoyance, there's increased potential for treatment gaps when people need to reschedule appointments. As a big pharma with more resources than Alexion had to work with, AstraZeneca could squeeze decades of healthy returns from its acquisition of Alexion.

davius
04/1/2021
16:47
You don't say!
beckers2008
04/1/2021
15:05
Lol, I'm short you idiot.
montyhedge
04/1/2021
14:57
Montyhedge,

Leave this BB and stick to the BB's that you have holdings, if you have any?

beckers2008
04/1/2021
14:34
Not the vaccine that will push Astra higher, great for mankind, but no great profits from it.It's the bid, deal won't be closed until 3rd quarter this year. So in the meantime a lot of movement up and down on the bid on news, are they paying to much, dilution, etc.
montyhedge
04/1/2021
08:11
Being televised now first person getting vaccine at Oxford Hospital, game changer, market is up on the news
triple witcher
03/1/2021
14:10
4 Reasons to Buy AstraZeneca Stock Now | The Motley Fool

For the Fool, this is a reasonable write up;

hxxps://www.fool.com/investing/2021/01/02/4-reasons-to-buy-astrazeneca-stock-now/

beckers2008
03/1/2021
12:55
azn vaccine approved for roll out in India. Its low cost and fridge temp storage will ensure its a winner.
coxsmn
03/1/2021
00:00
Well AZN got a New year Tip in the Friday Daily Telegraph for what its worth!
mercury123
02/1/2021
23:24
That is now out of date since they are only using one jab.
freddie ferret
02/1/2021
23:10
Vaccine priority list:
bountyhunter
02/1/2021
16:02
Montyhedge,

Do shares really go up and down? Well thanks for the advice, that's where I have been going wrong.

turvart
01/1/2021
13:22
Montyhedge,

Leave this BB and stick to the BB's that you have holdings, if you have any?

beckers2008
01/1/2021
13:18
Like I said shares go up and down, stop crying because Astra gone down, they will eventually go back up.
montyhedge
01/1/2021
12:03
Montyhedge,

Leave this BB and stick to the BB's that you have holdings, if you have any?

beckers2008
Chat Pages: Latest  150  149  148  147  146  145  144  143  142  141  140  139  Older

Your Recent History

Delayed Upgrade Clock